These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 8370689)

  • 1. Vertebral postmenopausal bone loss is reduced in overweight women: a longitudinal study in 155 early postmenopausal women.
    Tremollieres FA; Pouilles JM; Ribot C
    J Clin Endocrinol Metab; 1993 Sep; 77(3):683-6. PubMed ID: 8370689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor gene polymorphisms are not related to bone turnover, rate of bone loss, and bone mass in postmenopausal women: the OFELY Study.
    Garnero P; Borel O; Sornay-Rendu E; Arlot ME; Delmas PD
    J Bone Miner Res; 1996 Jun; 11(6):827-34. PubMed ID: 8725180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
    Al-Shoumer KA; Nair V
    Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is it possible to identify women with rapid vertebral bone loss during menopause? Result of a longitudinal study of 92 women at the onset of menopause].
    Pouillès JM; Trémollières F; Ribot C
    Rev Rhum Ed Fr; 1993 Mar; 60(3):217-22. PubMed ID: 8293008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
    Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
    J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of early age at menopause on vertebral bone mass.
    Pouillès JM; Trémollières F; Bonneu M; Ribot C
    J Bone Miner Res; 1994 Mar; 9(3):311-5. PubMed ID: 8191923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.
    Ravn P; Cizza G; Bjarnason NH; Thompson D; Daley M; Wasnich RD; McClung M; Hosking D; Yates AJ; Christiansen C
    J Bone Miner Res; 1999 Sep; 14(9):1622-7. PubMed ID: 10469292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between bone mineral density, weight, and estrogen levels in pre and postmenopausal women.
    Corina M; Vulpoi C; Brănişteanu D
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):946-50. PubMed ID: 23700870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
    Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
    N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of bone loss in menopausal Australian-born women.
    Guthrie JR; Ebeling PR; Hopper JL; Barrett-Connor E; Dennerstein L; Dudley EC; Burger HG; Wark JD
    Osteoporos Int; 1998; 8(3):282-90. PubMed ID: 9797914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.
    Trémollieres FA; Pouilles JM; Ribot C
    Osteoporos Int; 2001; 12(5):385-90. PubMed ID: 11444087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.
    Miklós S
    Acta Biomed Ateneo Parmense; 1995; 66(3-4):139-46. PubMed ID: 8578930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalent deficits in bone mass of the vertebral body and posterior processes in women with vertebral fractures: implications regarding the pathogenesis of spinal osteoporosis.
    Seeman E; Formica C; Mosekilde L
    J Bone Miner Res; 1995 Dec; 10(12):2005-10. PubMed ID: 8619382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on relationship between endogenous androgens and insulin resistance at the different stages of postmenopause].
    Cao YK; Zhang SF; Zou SE; Xia X; Xu LN
    Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):740-4. PubMed ID: 24406129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal bone loss in rheumatoid arthritis: effect of estrogens and androgens.
    Sambrook P; Birmingham J; Champion D; Kelly P; Kempler S; Freund J; Eisman J
    J Rheumatol; 1992 Mar; 19(3):357-61. PubMed ID: 1533677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women.
    Zhong N; Wu XP; Xu ZR; Wang AH; Luo XH; Cao XZ; Xie H; Shan PF; Liao EY
    Clin Chim Acta; 2005 Jan; 351(1-2):161-8. PubMed ID: 15563886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between body mass index and physical activity levels in relation to bone mineral density in premenopausal and postmenopausal women.
    Wee J; Sng BY; Shen L; Lim CT; Singh G; Das De S
    Arch Osteoporos; 2013; 8():162. PubMed ID: 24281832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy of established postmenopausal osteoporosis with monofluorophosphate plus calcium: dose-related effects on bone density and fracture rate.
    Ringe JD; Kipshoven C; Cöster A; Umbach R
    Osteoporos Int; 1999; 9(2):171-8. PubMed ID: 10367046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.